Analysis of in vivo absorption of didanosine tablets in male adult dogs by HPLC
Nenhuma Miniatura disponível
Data
2012-01-01
Autores
Severino, Patrícia
Silva, Heloisa [UNESP]
Souto, Eliana B.
Santana, Maria Helena A.
Dalla Costa, Teresa Cristina T.
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
Didanosine is an effective antiviral drug in untreated and antiretroviral therapy-experienced patients with Human Immunodeficiency Virus (HIV). An automated system using on-line solid extraction and High Performance Liquid Chromatography (HPLC) with ultraviolet (UV) detection was developed and validated for pharmacokinetic analysis of didanosine in dog plasma. Modifications were introduced on a previous methodology for simultaneous analysis of antiretroviral drugs in human plasma. Extraction was carried out on C18 cartridges, with high extraction yield as stationary phase, whereas mobile phase consisted of a mixture of 0.02 M potassium phosphate buffer, acetonitrile (KH2PO4: acetonitrile: 96:4, v/v) and 0.5% (w/v) of heptane sulphonic acid. The pH was adjusted to 6.5 with triethylamine. All samples and standard solutions were chromatographed at 28 °C. For an isocratic run, the flux was 1.0 mL/min, detection was at 250 nm and injected volume was 20 μL. The method was selective and linear for concentrations between 50 and 5000 ng/mL. Drug stability data ranged from 96% to 98%, and limit of quantification was 25 ng/mL. Extraction yield was up to 95%. Drug stability in dog plasma was kept frozen at -20 °C for one month after three freezethaw cycles, and for 24 h after processing in the auto sampler. Assay was successfully applied to measure didanosine concentrations in plasma dogs. © 2012 Xian Jiaotong University. Productionand hosting by Elsevier B.V. All rights reserved.
Descrição
Palavras-chave
Didanosine, HPLC, Male dogs, On-line solid phase extraction
Como citar
Journal of Pharmaceutical Analysis, v. 2, n. 1, p. 29-34, 2012.